Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand
•
0 recomendaciones•374 vistas
Recomendados
Más contenido relacionado
Destacado
Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand
- 1. Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand Report Details: Published:November 2012 No. of Pages: 221 Price: Single User License – US$3500 Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand Summary GBI Research’s report, “Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand” provides detailed insight into the global APIs market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the global APIs market. The report contains market forecasts, product type analysis, and drivers and restraints for growth. In addition, it includes therapeutic category analysis and contract manufacturing organizations’ (CMO) growth in the region, and their influence on API manufacturing activity towards 2017. Overall, the report presents a comprehensive analysis of the global APIs market, covering all the major parameters. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. The global APIs market was dominated by North America, which generated 35.1% of global API revenues in 2011. The Asia-Pacific region also saw high growth, second behind North America with a revenue share of 29.7% in 2011. The global APIs market revenues reached $108,613m in 2011. In the product-based segments, the synthetic market dominated the market with 82.7% of global APIs revenues. However, increasing acceptance and increasing penetration are boosting the biopharmaceuticals drug market in both developed and developing economies. Scope
- 2. - Market revenue data for APIs from 2005 to 2011, forecast forward for six years to 2017. - API markets in the regions of North America, Asia-Pacific and Europe, along with key countries such as the US, Canada, Japan, China, South Korea, India, Italy, Germany, France, the UK and Spain. - API industry structure and market trends, such as a shift in manufacturing and growth in biotechnology globally. - Drivers and restraints for the global APIs market. - Detailed historical, forecast trend and share analysis of API revenues based on product types (synthetic and biotechnology APIs) at the global, regional and key country levels. - Detailed historical and forecast trends and share analysis for API revenues based on the customer base (generic and innovative for synthetic APIs, biosimilars and biologics for biotech APIs) at the global, regional and key country levels. - Analysis of API revenues based on therapeutic categories at a global and regional level. Reasons to buy - Develop business strategies with the help with specific insights in the global API market. - Identify opportunities and challenges in the global API market. - Invest in the growing segments of the APIs market. - Increase future revenue and profitability with the help of insights into the future opportunities and critical success factors in the global APIs market. - Benchmark your operations and strategies against the major players in the global APIs market. Get your copy of this report @ http://www.reportsnreports.com/reports/206056-active-pharmaceutical-ingredients-api-global-market-to-2017- growth-in-developing-markets-to-come-from-cost-efficient-manufacturing-and-rising-domestic-demand.html Major points covered in Table of Contents of this report include 1 Table of Contents 1 Table of Contents 6 1.1 List of Tables 10 1.2 List of Figures 12 2 Introduction 15 3 Global Active Pharmaceutical Ingredients Market 16 3.1 Global API Market Overview 16 3.2 Global API Market Drivers 16 3.2.1 Patent Expiries to Change the Dynamics of the Global API Market 16 3.2.2 Increased Uptake of Biologics Across Different Therapeutic Areas and Government Initiatives for Biomedical Research Set to Boost API Revenues 16 3.2.3 Increased Mergers and Acquisitions to Drive Global Pharmaceutical Industry Growth 16 3.2.4 Increasing Geographical Penetration and Elderly Population to Drive Growth of the Global Pharmaceutical and API Markets 16 3.2.5 Patent Expiries of Major Drugs to Support Pharmaceutical Market Revenue Growth in
- 3. Underpenetrated Markets 17 3.3 Global API Market Restraints 17 3.3.1 Economic Recession to Restrict Investment in the Pharmaceutical Industry 17 3.3.2 Limited Improvement in Pharmaceutical Manufacturing Capabilities May Reduce Overall Growth Potential 17 3.3.3 Increasing Patent Expiries to Impede Growth of the Global API Market 17 3.3.4 Regulatory Changes to Delay the Launch of New Drugs 18 3.4 Global API Market Revenue Analysis and Forecast to 2017 19 3.4.1 Global API Market Revenue Share by Product Type 21 3.4.2 Global Synthetic Market Revenue Analysis and Forecast to 2017 22 3.4.3 Global Synthetic Market Revenue Share Analysis by Customer Base 26 3.4.4 Global Synthetic Market Revenue Analysis and Forecast to 2017 27 3.5 Global Biotech Market Analysis 29 3.5.1 Global Biotech Market Revenue Analysis and Forecast to 2017 29 3.6 Global Biotech Market Revenue Analysis by Customer Base 34 3.6.1 Global Biotech Market Revenue Share Analysis by Customer Base 34 3.6.2 Global Biotech Market Revenue Analysis and Forecast to 2017 35 3.7 Global Contract Manufacturing Organizations 37 3.7.1 Global CMO Outsourcing Process 38 3.7.2 Global CMO Market Drivers 39 3.7.3 Global CMO Market Outsourcing Benefits 40 3.7.4 Global CMO Market Revenues and Forecast to 2017 41 4 North America Active Pharmaceutical Ingredients Market 43 4.1 North America API Market Overview 43 4.2 North America API Market Drivers 43 4.2.1 Continuous Growth in the Pharmaceutical Industry to Sustain API Market Growth in North America 43 4.2.2 Generic Sector Supports the Growth of the North American API Market 43 4.2.3 Increasing Focus on Biological Drugs to Support API Market Revenue Growth 43 4.3 North American API Market Restraints 44 4.3.1 Recent Economic Slowdown has Restricted Pharmaceutical Industry Growth 44 4.3.2 High Cost of New Drug Development Hampers Innovation 44 4.3.3 Patent Expiries of Blockbuster Molecules to Contain API Market Growth in North America 44 4.4 North America API Market Revenue Analysis and Forecast to 2017 45 4.5 North America API Market Revenue Share Analysis by Product Type 47 4.6 North America Synthetic Market Analysis 48 4.6.1 North America Synthetic Market Revenue Analysis and Forecast to 2017 48 4.6.2 North America Synthetic Market Revenue Share Analysis by Customer Base 53 4.6.3 North America Synthetic Market Revenue Analysis by Customer Base and Forecast to 2017 54 4.7 North America Biotech Market Analysis 56 4.7.1 North America Biotech Market Revenue Analysis and Forecast to 2017 56
- 4. 4.7.2 North America Biotech Market Revenue Share Analysis by Customer Base 61 4.7.3 North America Biotech Market Revenue Analysis by Customer Base and Forecast to 2017 62 4.8 North America API Market Revenue Share Analysis by Therapeutic Applications 64 4.9 The US Active Pharmaceutical Ingredients Market 65 4.9.1 The US API Market Overview 65 4.9.2 The US API Market Revenue by Product Type and Forecast to 2017 66 4.9.3 The US API Market Revenue Share Analysis by Product Type and Forecast to 2017 68 4.9.4 The US API Market by Customer Base 69 4.10 Canada Active Pharmaceutical Ingredients Market 75 4.10.1 Canada API Market Overview 75 4.10.2 Canada API Market Revenue Analysis by Product Type and Forecast to 2017 75 4.10.3 Canada API Market Revenue Share Analysis by Product Types and Forecast to 2017 77 4.10.4 Canada API Market by Customer Base 78 5 Asia-Pacific Active Pharmaceutical Ingredients Market 84 5.1 Asia-Pacific API Market Overview 84 5.2 Asia-Pacific APIs Market Drivers 85 5.2.1 Pharmaceutical Manufacturing Capabilities in Developing Countries such as China and India to Attract API Manufacture 85 5.2.2 Domestic Market Growth of Developing Countries in Asia-Pacific to Drive Global Pharmaceutical Industry Growth 85 5.2.3 Increasing Focus on Biotech API Drugs in Asia-Pacific will Contribute to Major Asia-Pacific API Market Growth 85 5.2.4 Improving Regulatory Framework in China and India is Increasing Penetration for Branded Drugs 85 5.2.5 Patent Expiries of Blockbuster Drugs to Boost Market Revenues in Asia-Pacific Markets 85 5.3 Asia-Pacific API Market Restraints 86 5.3.1 Increasing Incidence of Patent Expiries to Hamper Growth for Branded API Market 86 5.3.2 Highly Fragmented Market to Restrict Revenue Growth for the Asia-Pacific API Market 86 5.3.3 Limited Improvement in Pharmaceutical Manufacturing Capabilities may Hamper Overall Growth Potential 86 5.3.4 Currency Fluctuations to Hamper Value Growth of Pharmaceutical Market in Asia-Pacific Region 86 5.4 Asia-Pacific API Market Revenue and Forecasts to 2017 87 5.5 Asia-Pacific Revenue Share Analysis by Product Type 89 5.6 Asia-Pacific Synthetic Market 90 5.6.1 Asia-Pacific Synthetic Market Revenues and Forecast to 2017 90 5.6.2 Asia-Pacific Synthetic Market Revenue Share Analysis by Consumer Base 95 5.6.3 Asia-Pacific Synthetic Market Revenues by Customer Base and Forecast to 2017 96 5.7 Asia-Pacific Biotech Market 98 5.7.1 Asia-Pacific Biotech Market Revenues and Forecasts to 2017 98 5.7.2 Asia-Pacific Biotech Market Revenue Share Analysis by Customer Base 104
- 5. 5.7.3 Asia-Pacific Biotech Market Revenue by Customer Base and Forecast to 2017 105 5.8 Asia-Pacific API Market Share Analysis by Therapeutic Applications 107 5.9 Japan Active Pharmaceutical Ingredients Market 108 5.9.1 Japan API Market Overview 108 5.9.2 Japan API Market Revenues and Forecasts to 2017 108 5.9.3 Japan API Market Revenue Share Analysis by Product Type 110 5.9.4 Japan API Market by Customer Base 111 5.10 China Active Pharmaceutical Ingredients Market 117 5.10.1 China API Market Overview 117 5.10.2 China API Market Revenues by Product Type and Forecasts to 2017 118 5.10.3 China API Market Revenue Share Analysis by Product Types 120 5.10.4 China API Market by Customer Base 121 5.11 South Korea Active Pharmaceutical Ingredients Market 127 5.11.1 South Korea API Market Overview 127 5.11.2 South Korea APIs Market Revenue and Forecasts to 2017 128 5.11.3 South Korea API Market Revenue Share Analysis by Product Type 130 5.11.4 South Korea API Market by Customer Base 131 5.12 India Active Pharmaceutical Ingredients Market 137 5.12.1 India API Market Overview 137 5.12.2 India API Market Revenue and Forecasts to 2017 138 5.12.3 India API Market Revenue Share Analysis by Product Types 140 5.12.4 India API Market by Customer Base 141 6 Europe Active Pharmaceutical Ingredients Market 147 6.1 Europe API Market Overview 147 6.2 Europe API Market Drivers 147 6.2.1 Increased CMO Opportunities Expected to Improve the Production of Generics and Drive API Revenue Growth in Europe 147 6.2.2 Overall Growth in the Pharmaceutical Industry and Increasing Elderly Population to Drive the Growth for the European API Market 147 6.2.3 Biopharmaceutical Therapies to Support API Market Growth in Europe 147 6.2.4 European Regulatory Framework to Facilitate Development of Biosimilars 147 6.2.5 Differences in VAT rates on Pharma Products to Increase Parallel Trade in Europe 147 6.3 Europe API Market Restraints 148 6.3.1 Increased Consumption of Generics to Limit the Premium Earned from Branded Products 148 6.3.2 Increasing Patent Expiries to Hamper the Growth of the European API Market 148 6.3.3 Price Cuts to Restrict Revenue Growth for the European API Market 149 6.4 Europe API Market Revenue Analysis and Forecast to 2017 151 6.5 Europe API Market Revenue Share Analysis by Product Type 153 6.6 Europe Synthetic Market Analysis 154 6.6.1 Europe Synthetic Market Revenue Analysis and Forecast to 2017 154 6.6.2 European Synthetic Market Revenue Share Analysis by Customer Base 159
- 6. 6.6.3 Europe Synthetic Market Revenue by Customer Base and Forecast to 2017 160 6.7 Europe Biotech Market Analysis 162 6.7.1 Europe Biotech Market Revenue Analysis and Forecast to 2017 162 6.7.2 Europe Biotech Market Revenue Share Analysis by Customer Base 167 6.7.3 Europe Biotech Market Revenues by Customer Base and Forecast to 2017 168 6.8 Europe API Market Revenue Share Analysis by Therapeutic Applications 170 6.9 Germany Active Pharmaceutical Ingredients Market 172 6.9.1 Germany API Market Overview 172 6.9.2 Germany API Market Revenue Analysis by Product Type and Forecast to 2017 172 6.9.3 Germany API Market Revenue Share Analysis by Product Type and Forecast to 2017 174 6.9.4 Germany API Market by Customer Base 175 6.10 France Active Pharmaceutical Ingredients Market 181 6.10.1 France API Market Overview 181 6.10.2 France API Market Revenue Analysis by Product Type and Forecast to 2017 181 6.10.3 France API Revenue Share Analysis by Product Type and Forecast to 2017 183 6.10.4 France API Market by Customer Base 184 6.11 Italy Active Pharmaceutical Ingredients Market 190 6.11.1 Italy API Market Overview 190 6.11.2 Italy API Market Revenue Analysis by Product Type and Forecast to 2017 190 6.11.3 Italy API Market Revenue Share Analysis by Product Type and Forecast to 2017 192 6.11.4 Italy API Market by Customer Base 193 6.12 The UK Active Pharmaceutical Ingredients Market 199 6.12.1 The UK API Market Overview 199 6.12.2 The UK API Market Revenue Analysis by Product Type and Forecast to 2017 199 6.12.3 The UK API Market Revenue Share Analysis by Product Types and Forecast to 2017 201 6.12.4 The UK API Market by Customer Base 202 6.13 Spain Active Pharmaceutical Ingredients Market 208 6.13.1 Spain API Market Overview 208 6.13.2 Spain API Market Revenue Analysis by Product Type and Forecast to 2017 208 6.13.3 Spain API Market Revenue Share Analysis by Product Types and Forecast to 2017 210 6.13.4 Spain API Market by Customer Base 211 7 Appendix 217 7.1 Abbreviations 217 7.2 Bibliography 218 7.3 Market Definitions 219 7.4 Methodology 219 7.4.1 Coverage 219 7.4.2 Secondary Research 220 7.4.3 Primary Research 220 7.4.4 Expert Panel Validation 220 7.5 Contact Us 221 7.6 Disclaimer 221
- 7. 1.1 List of Tables Table 1: API Market, Global, Total Revenue Analysis, $m, 2005–2017 20 Table 2: API Market, Global, Revenue Share by Product Types, %, 2011 21 Table 3: Synthetic Market, Global, Revenue Analysis, $m, 2005–2017 23 Table 4: Synthetic Market, Global, Revenue Share Analysis by Region, %, 2011 24 Table 5: Synthetic Market, Global, Revenue Share Analysis by Region, %, 2005–2017 25 Table 6: Synthetic Market, Global, Revenue Share by Customer Base, %, 2011 26 Table 7: Synthetic Market, Global, Revenue Analysis by Customer Base, $m, 2005–2017 28 Table 8: Biotech Market, Global, Revenue Analysis, $m, 2005–2017 30 Table 9: Biotech Market, Global, Revenue Share by Region, %, 2011 31 Table 10: Biotech Market, Global, Revenue Share Analysis by Region, %, 2005–2017 33 Table 11: Biotech Market, Global, Revenue Share Analysis by Customer Base, %, 2011 34 Table 12: Biotech Market, Global, Revenue Analysis by Customer Base, $m, 2005–2017 36 Table 13: CMO Market, Asia-Pacific, Fine Chemical Industry Labor Cost, $/Operator/Year, 2011 39 Table 14: CMO Market, Global, Market Revenues, $m, 2005–2017 42 Table 15: API Market, North America, Major Drugs to Lose Patent Protection, 2012–2016 44 Table 16: API Market, North America, Revenue Analysis by Product Type, $m, 2005–2017 46 Table 17: API Market, North America, Revenue Share by Product Type, %, 2005–2017 47 Table 18: Synthetic Market, North America, Revenue Analysis, $m, 2005–2017 49 Table 19: Synthetic Market, North America, Revenue Share Analysis by Countries, $m and %, 2011 50 Table 20: Synthetic Market, North America, Revenue Share Trend, %, 2005–2017 52 Table 21: Synthetic Market, North America, Revenue Share by Customer Base, (%), 2011 53 Table 22: Synthetic Market, North America, Revenue Analysis by Customer Base, $m, 2005–2017 55 Table 23: Biotech Market, North America, Revenue Analysis, $m, 2005–2017 57 Table 24: Biotech Market, North America, Revenue Share by Countries, $m and %, 2011 58 Table 25: Biotech Market, North America, Revenue Share Trend, %, 2005–2017 60 Table 26: Biotech Market, North America, Revenue Share Analysis by Customer Base, %, 2011 61 Table 27: Biotech Market, North America, Revenue Analysis by Customer Base, $m, 2005–2017 63 Table 28: API Market, North America, Revenue Split by Therapeutic Applications, %, 2011–2017 65 Table 29: API Market, The US, Revenue Analysis by Product Type, $m, 2005–2017 67 Table 30: API Market, The US, Revenue Share Analysis by Product Type, %, 2005–2017 68 Table 31: Synthetic Market, The US, Revenue Analysis by Customer Base, $m, 2005–2017 70 Table 32: Synthetic Market, The US, Revenue Share by Customer Base, %, 2005–2017 71 Table 33: Biotech Market, The US, Revenue Analysis by Customer Base, $m, 2005–2017 73 Table 34: Biotech Market, The US, Revenue Share by Customer Base, %, 2005–2017 74
- 8. Table 35: API Market, Canada, Revenue Analysis by Product Type, $m, 2005–2017 76 Table 36: API Market, Canada, Revenue Share by Product Type, %, 2005–2017 77 Table 37: Synthetic Market, Canada, Revenue Analysis by Customer Base, $m, 2005–2017 79 Table 38: Synthetic Market, Canada, Revenue Share by Customer Base, %, 2005–2017 80 Table 39: Biotech Market, Canada, Revenue Analysis by Customer Base, $m, 2005–2017 82 Table 40: Biotech Market, Canada, Revenue Share by Customer Base, %, 2005–2017 83 Table 41: API Market, Asia-Pacific, Market Revenues, $m, 2005–2017 88 Table 42: API Market, Asia-Pacific, Revenue Share by Product Types, $m and %, 2011 89 Table 43: Synthetic Market, Asia-Pacific, Market Revenues, $m, 2005–2017 91 Table 44: Synthetic Market, Asia-Pacific, Revenue Share Analysis by Countries, $m and %, 2011 92 Table 45: Synthetic Market, Asia-Pacific, Revenue Analysis by Countries, $m, 2005–2017 95 Table 46: Synthetic Market, Asia-Pacific, Revenue Share by Customer Base, %, 2011 95 Table 47: Synthetic Market, Asia-Pacific, Market Revenues by Product Types, $m, 2005–2017 97 Table 48: Biotech Market, Asia-Pacific, Market Revenues, $m, 2005–2017 99 Table 49: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries, $m and %, 2011 100 Table 50: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries, $m, 2005, 2011 and 2017 103 Table 51: Biotech Market, Asia-Pacific, Revenue Share Analysis by Customer Base, $m and %, 2011 104 Table 52: Biotech Market, Asia-Pacific, Market Revenues by Product Type, $m, 2005–2017 106 Table 53: API Market, Asia-Pacific, Revenue Share Analysis by Therapeutic Applications, %, 2011–2017 107 Table 54: API Market, Japan, Market Revenues by Product Types, $m, 2005–2017 109 Table 55: API Market, Japan, Revenue Share Analysis by Product Types, %, 2005–2017 110 Table 56: Synthetic Market, Japan, Market Revenues by Customer Base, $m, 2005–2017 112 Table 57: Synthetic Market, Japan, Revenue Share by Customer Base, %, 2005–2017 113 Table 58: Biotech Market, Japan, Market Revenues by Customer Base, $m, 2005–2017 115 Table 59: Biotech Market, Japan, Revenue Share Analysis by Customer Base, %, 2005–2017 116 Table 60: API Market, China, Market Revenues by Product Type, $m, 2005–2017 119 Table 61: API Market, China, Revenue Share Analysis by Product Type, %, 2005–2017 120 Table 62: Synthetic Market, China, Market Revenues by Customer Base, $m, 2005–2017 122 Table 63: Synthetic Market, China, Revenue Share Analysis by Customer Base, %, 2005–2017 123 Table 64: Biotech Market, China, Market Revenues by Customer Base, $m, 2005–2017 125 Table 65: Biotech Market, China, Revenue Share Analysis by Customer Base, %, 2005–2017 126 Table 66: API Market, South Korea, Market Revenues by Product Types, $m, 2005–2017 129 Table 67: API Market, South Korea, Revenue Share Analysis by Product Types, %, 2005–2017 130 Table 68: Synthetic Market, South Korea, Market Revenues by Customer Base, $m, 2005–2017 132
- 9. Table 69: Synthetic Market, South Korea, Revenue Share Analysis by Customer Base, %, 2005–2017 133 Table 70: Biotech Market, South Korea, Market Revenues by Customer Base, $m, 2005–2017 135 Table 71: Biotech Market, South Korea, Revenue Share Analysis by Customer Base, %, 2005–2017 136 Table 72: API Market, India, Market Revenues by Product Types, $m, 2005–2017 139 Table 73: API Market, India, Revenue Share Analysis by Product Types, %, 2005–2017 140 Table 74: Synthetic Market, India, Market Revenues by Customer Base, $m, 2005–2017 142 Table 75: Synthetic Market, India, Revenue Share Analysis by Customer Base, %, 2005–2017 143 Table 76: Biotech Market, India, Market Revenues by Customer Base, $m, 2005–2017 145 Table 77: Biotech Market, India, Revenue Share Analysis by Customer Base, %, 2005–2017 146 Table 78: Pharmaceutical Market, Leading Five European Countries, Pricing and Reimbursement Mechanism, 2011 149 Table 79: API Market, Europe, Total Revenue Analysis, $m, 2005–2017 152 Table 80: API Market, Europe, Revenue Share by Product Types, %, 2011 153 Table 81: Synthetic Market, Europe, Revenue Analysis, $m, 2005–2017 155 Table 82: Synthetic Market, Europe, Revenue Share Analysis by Countries, %, 2011 156 Table 83: Synthetic Market, Europe, Revenue Share Trend, %, 2005–2017 158 Table 84: Synthetic Market, Europe, Revenue Share by Customer Base, %, 2011 159 Table 85: Synthetic Market, Europe, Revenue Analysis by Customer Base, $m, 2005–2017 161 Table 86: Biotech Market, Europe, Revenue Analysis, $m, 2005–2017 163 Table 87: Biotech Market, Europe, Revenue Share by Countries, %, 2011 164 Table 88: Biotech Market, Europe, Revenue Share Trend, %, 2005–2017 166 Table 89: Biotech Market, Europe, Revenue Share Analysis by Customer Base, %, 2011 167 Table 90: Biotech Market, Europe, Revenue Analysis by Customer Base, $m, 2005–2017 169 Table 91: API Market, Europe, Revenue Split by Therapeutic Applications, %, 2011–2017 171 Table 92: API Market, Germany, Revenue Analysis by Product Types, $m, 2005–2017 173 Table 93: API Market, Germany, Revenue Share by Product Type, %, 2005–2017 174 Table 94: Synthetic Market, Germany, Revenue Analysis by Customer Base, $m, 2005–2017 176 Table 95: Synthetic Market, Germany, Revenue Share by Customer Base, %, 2005–2017 177 Table 96: Biotech Market, Germany, Revenue Analysis by Customer Base, $m, 2005–2017 179 Table 97: Biotech Market, Germany, Revenue Share by Customer Base, %, 2005–2017 180 Table 98: API Market, France, Revenue Analysis by Product Types, $m, 2005–2017 182 Table 99: API Market, France, Revenue Share by Product Type, %, 2005–2017 183 Table 100:Synthetic Market, France, Revenue Analysis by Customer Base, $m, 2005–2017 185 Table 101:Synthetic Market, France, Revenue Share by Customer Base, %, 2005–2017 186 Table 102:Biotech Market, France, Revenue Analysis by Customer Base, $m, 2005–2017 188 Table 103:Biotech Market, France, Revenue Share by Customer Base, %, 2005–2017 189 Table 104:API Market, Italy, Revenue Analysis by Product Types, $m, 2005–2017 191 Table 105:API Market, Italy, Revenue Share by Product Type, %, 2005–2017 192 Table 106:Synthetic Market, Italy, Revenue Analysis by Customer Base, $m, 2005–2017 194 Table 107:Synthetic Market, Italy, Revenue Share by Customer Base, %, 2005–2017 195
- 10. Table 108:Biotech Market, Italy, Revenue Analysis by Customer Base, $m, 2005–2017 197 Table 109:Biotech Market, Italy, Revenue Share by Customer Base, %, 2005–2017 198 Table 110:API Market, The UK, Revenue Analysis by Product Types, $m, 2005–2017 200 Table 111:API Market, The UK, Revenue Share by Product Type, %, 2005–2017 201 Table 112:Synthetic Market, The UK, Revenue Analysis by Customer Base, $m, 2005–2017 203 Table 113:Synthetic Market, The UK, Revenue Share by Customer Base, %, 2005–2017 204 Table 114:Biotech Market, The UK, Revenue Analysis by Customer Base, $m, 2005–2017 206 Table 115:Biotech Market, The UK, Revenue Share by Customer Base, %, 2005–2017 207 Table 116:API Market, Spain, Revenue Analysis by Product Types, $m, 2005–2017 209 Table 117:API Market, Spain, Revenue Share by Product Type, %, 2005–2017 210 Table 118:Synthetic Market, Spain, Revenue Analysis by Customer Base, $m, 2005–2017 212 Table 119:Synthetic Market, Spain, Revenue Share by Customer Base, %, 2005–2017 213 Table 120:Biotech Market, Spain, Revenue Analysis by Customer Base, $m, 2005–2017 215 Table 121:Biotech Market, Spain, Revenue Share by Customer Base, %, 2005–2017 216 1.2 List of Figures Figure 1: API Market, Global, Total Revenue Analysis ($m), 2005–2017 19 Figure 2: API Market, Global, Revenue Share by Product Type (%), 2011 21 Figure 3: Synthetic Market, Global, Revenue Analysis ($m), 2005–2017 22 Figure 4: Synthetic Market, Global, Revenue Share Analysis (%), 2011 24 Figure 5: Synthetic Market, Global, Revenue Share Analysis by Region (%), 2005–2017 25 Figure 6: Synthetic Market, Global, Revenue Share by Customer Base (%), 2011 26 Figure 7: Synthetic Market, Global, Revenue Analysis by Customer Base ($m), 2005–2017 27 Figure 8: Biotech Market, Global, Revenue Analysis ($m), 2005–2017 29 Figure 9: Biotech Market, Global, Revenue Share by Region (%), 2011 31 Figure 10: Biotech Market, Global, Revenue Share Analysis by Region (%), 2005–2017 32 Figure 11: Biotech Market, Global, Revenue Share Analysis by Customer Base (%), 2011 34 Figure 12: Biotech Market, Global, Revenue Analysis by Customer Base ($m), 2005–2017 35 Figure 13: CMO Market, Global, Process for Selection of CMO and Management of Outsourcing Project 38 Figure 14: CMO Market, Asia-Pacific, Fine Chemical Industry Labor Cost ($/Operator/Year), 2011 39 Figure 15: CMO Market Key Benefits of Outsourcing to CMOs 40 Figure 16: CMO Market, Global, Market Revenue ($m), 2005-2017 41 Figure 17: API Market, North America, Revenue Analysis by Product Type ($m), 2005–2017 45 Figure 18: API Market, North America, Revenue Share by Product Type (%), 2005–2017 47 Figure 19: Synthetic Market, North America, Revenue Analysis ($m), 2005–2017 48 Figure 20: Synthetic Market, North America, Revenue Share Analysis by Countries (%), 2011 50 Figure 21: Synthetic Market, North America, Performance and Potential Analysis Grid (%), 2005–2017 51 Figure 22: Synthetic Market, North America, Revenue Share Trend Analysis by Countries (%), 2005–2017 52
- 11. Figure 23: Synthetic API, North America, Revenue Share by Customer Base (%), 2011 53 Figure 24: Synthetic Market, North America, Revenue Analysis by Customer Base ($m), 2005–2017 54 Figure 25: Biotech Market, North America, Revenue Analysis ($m and %), 2005–2017 56 Figure 26: Biotech Market, North America, Revenue Share by Countries (%), 2011 58 Figure 27: Biotech Market, North America, Performance and Potential Analysis Grid (%), 2005–2017 59 Figure 28: Biotech Market, North America, Revenue Share Trend (%), 2005–2017 60 Figure 29: Biotech Market, North America, Revenue Share Analysis by Customer Base (%), 2011 61 Figure 30: Biotech Market, North America, Revenue Analysis by Customer Base ($m), 2005–2017 62 Figure 31: API Market, North America, Revenue Split by Therapeutic Applications (%), 2011–2017 64 Figure 32: API Market, The US, Revenue Analysis by Product Type ($m), 2005–2017 66 Figure 33: API Market, The US, Revenue Share Analysis by Product Type (%), 2005–2017 68 Figure 34: Synthetic Market, The US, Revenue Analysis by Customer Base ($m), 2005–2017 69 Figure 35: Synthetic Market, The US, Revenue Share by Customer Base (%), 2005–2017 71 Figure 36: Biotech API, The US, Revenue Analysis by Customer Base ($m), 2005–2017 72 Figure 37: Biotech Market, The US, Revenue Share by Customer Base (%), 2005–2017 74 Figure 38: API Market, Canada, Revenue Analysis by Product Type ($m), 2005–2017 75 Figure 39: API Market, Canada, Revenue Share by Product Type (%), 2005–2017 77 Figure 40: Synthetic Market, Canada, Revenue Analysis by Customer Base ($m), 2005–2017 78 Figure 41: Synthetic Market, Canada, Revenue Share by Customer Base (%), 2005–2017 80 Figure 42: Biotech Market, Canada, Revenue Analysis by Customer Base ($m), 2005–2017 81 Figure 43: Biotech Market, Canada, Revenue Share by Customer Base (%), 2005–2017 83 Figure 44: API Market, Asia-Pacific, Market Revenues ($m), 2005–2017 87 Figure 45: API Market, Asia-Pacific, Revenue Share by Product Type (%), 2011 89 Figure 46: Synthetic Market, Asia-Pacific, Market Revenues ($m), 2005–2017 90 Figure 47: Synthetic Market, Asia-Pacific, Revenue Share Analysis by Countries (%), 2011 92 Figure 48: Synthetic Market, Asia-Pacific, Performance and Potential Analysis Grid (%), 2005–2017 93 Figure 49: Synthetic Market, Asia-Pacific, Revenue Analysis by Countries (%), 2005–2017 94 Figure 50: Synthetic Market, Asia-Pacific, Revenue Share by Customer Base (%), 2011 95 Figure 51: Synthetic Market, Asia-Pacific, Revenue Trend Analysis by Product Type ($m), 2005–2017 96 Figure 52: Biotech Market, Asia-Pacific, Market Revenues ($m and %), 2005–2017 98 Figure 53: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries (%), 2011 100 Figure 54: Biotech Market, Asia-Pacific, Performance and Potential Analysis Grid (%), 2005–2017 101 Figure 55: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries ($m), 2005–2017 102
- 12. Figure 56: Biotech Market, Asia-Pacific, Revenue Share Analysis by Customer Base (%), 2011 104 Figure 57: Biotech Market, Asia-Pacific, Market Revenues by Product Type ($m), 2005–2017 105 Figure 58: API Market, Asia-Pacific, Revenue Share Analysis by Therapeutic Applications (%), 2011–2017 107 Figure 59: API Market, Japan, Market Revenues by Product Type ($m), 2005–2017 108 Figure 60: API Market, Japan, Revenue Share Analysis by Product Types (%), 2005–2017 110 Figure 61: Synthetic Market, Japan, Market Revenues by Customer Base ($m), 2005–2017 111 Figure 62: Synthetic Market, Japan, Revenue Share by Customer Base (%), 2005–2017 113 Figure 63: Biotech Market, Japan, Market Revenues by Customer Base ($m), 2005–2017 114 Figure 64: Biotech Market, Japan, Revenue Share Analysis by Customer Base (%), 2005–2017 116 Figure 65: API Market, China, Market Revenues by Product Type ($m), 2005–2017 118 Figure 66: API Market, China, Revenue Share Analysis by Product Type (%), 2005–2017 120 Figure 67: Synthetic Market, China, Market Revenues by Customer Base ($m), 2005–2017 121 Figure 68: Synthetic Market, China, Revenue Share Analysis by Customer Base (%), 2005–2017 123 Figure 69: Biotech Market, China, Market Revenues by Customer Base ($m), 2005–2017 124 Figure 70: Biotech Market, China, Revenue Share Analysis by Customer Base (%), 2005–2017 126 Figure 71: API Market, South Korea, Market Revenues by Product Type ($m), 2005–2017 128 Figure 72: API Market, South Korea, Revenue Share Analysis by Product Types (%), 2005–2017 130 Figure 73: Synthetic Market, South Korea, Market Revenues by Customer Base ($m), 2005–2017 131 Figure 74: Synthetic Market, South Korea, Revenue Share Analysis by Customer Base (%), 2005–2017 133 Figure 75: Biotech Market, South Korea, Market Revenues by Customer Base ($m), 2005–2017 134 Figure 76: Biotech Market, South Korea, Revenue Share Analysis by Customer Base (%), 2005–2017 136 Figure 77: API Market, India, Market Revenues by Product Types ($m), 2005–2017 138 Figure 78: API Market, India, Revenue Share Analysis by Product Types (%), 2005–2017 140 Figure 79: Synthetic Market, India, Market Revenues by Customer Base ($m), 2005–2017 141 Figure 80: Synthetic Market, India, Revenue Share Analysis by Customer Base (%), 2005–2017 143 Figure 81: Biotech Market, India, Market Revenues by Customer Base ($m), 2005–2017 144 Figure 82: Biotech Market, India, Revenue Share Analysis by Customer Base (%), 2005–2017 146 Figure 83: API Market, Europe, Total Revenue Analysis ($m), 2005–2017 151 Figure 84: API Market, Europe, Revenue Share by Product Types (%), 2011 153 Figure 85: Synthetic Market, Europe, Revenue Analysis ($m), 2005–2017 154 Figure 86: Synthetic Market, Europe, Revenue Share Analysis by Countries (%), 2011 156
- 13. Figure 87: Synthetic Market, Europe, Performance and Potential Analysis Grid (%), 2005–2017 157 Figure 88: Synthetic Market, Europe, Revenue Share Trend Analysis by Countries (%), 2005–2017 158 Figure 89: Synthetic Market, Europe, Revenue Share by Customer Base, (%), 2011 159 Figure 90: Synthetic Market, Europe, Revenue Trend by Product Types ($m), 2005–2017 160 Figure 91: Biotech Market, Europe, Revenue Analysis ($m and %), 2005–2017 162 Figure 92: Biotech Market, Europe, Revenue Share by Countries (%), 2011 164 Figure 93: Biotech Market, Europe, Performance and Potential Analysis Grid (%), 2005–2017 165 Figure 94: Biotech Market, Europe, Revenue Share Trend (%), 2005–2017 166 Figure 95: Biotech Market, Europe, Revenue Share Analysis by Customer Base (%), 2011 167 Figure 96: Biotech Market, Europe, Revenue Analysis by Customer Base ($m), 2005–2017 168 Figure 97: API Market, Europe, Revenue Split by Therapeutic Applications (%), 2011–2017 170 Figure 98: API Market, Germany, Revenue Analysis by Product Types ($m), 2005–2017 172 Figure 99: API Market, Germany, Revenue Share by Product Type (%), 2005–2017 174 Figure 100: Synthetic Market, Germany, Revenue Analysis by Customer Base ($m), 2005–2017 175 Figure 101: Synthetic Market, Germany, Revenue Share by Customer Base (%), 2005–2017 177 Figure 102: Biotech Market, Germany, Revenue Analysis by Customer Base ($m), 2005–2017 178 Figure 103: Biotech Market, Germany, Revenue Share by Customer Base (%), 2005–2017 180 Figure 104: API Market, France, Revenue Analysis by Product Types ($m), 2005–2017 181 Figure 105: API Market, France, Revenue Share by Product Type (%), 2005–2017 183 Figure 106: Synthetic Market, France, Revenue Analysis by Customer Base ($m), 2005–2017 184 Figure 107: Synthetic Market, France, Revenue Share by Customer Base (%), 2005–2017 186 Figure 108: Biotech Market, France, Revenue Analysis by Customer Base ($m), 2005–2017 187 Figure 109: Biotech Market, France, Revenue Share by Customer Base (%), 2005–2017 189 Figure 110: API Market, Italy, Revenue Analysis by Product Types ($m), 2005–2017 190 Figure 111: API Market, Italy, Revenue Share by Product Type (%), 2005–2017 192 Figure 112: Synthetic Market, Italy, Revenue Analysis by Customer Base ($m), 2005–2017 193 Figure 113: Synthetic Market, Italy, Revenue Share by Customer Base (%), 2005–2017 195 Figure 114: Biotech Market, Italy, Revenue Analysis by Customer Base ($m), 2005–2017 196 Figure 115: Biotech Market, Italy, Revenue Share by Customer Base (%), 2005–2017 198 Figure 116: API Market, The UK, Revenue Analysis by Product Types ($m), 2005–2017 199 Figure 117: API Market, The UK, Revenue Share by Product Type (%), 2005–2017 201 Figure 118: Synthetic Market, The UK, Revenue Analysis by Customer Base ($m), 2005–2017 202 Figure 119: Synthetic Market, The UK, Revenue Share by Customer Base (%), 2005–2017 204 Figure 120: Biotech Market, The UK, Revenue Analysis by Customer Base ($m), 2005–2017 205 Figure 121: Biotech Market, The UK, Revenue Share by Customer Base (%), 2005–2017 207 Figure 122: API Market, Spain, Revenue Analysis by Product Types ($m), 2005–2017 208 Figure 123: API Market, Spain, Revenue Share by Product Type (%), 2005–2017 210 Figure 124: Synthetic Market, Spain, Revenue Analysis by Customer Base ($m), 2005–2017 211
- 14. Figure 125: Synthetic Market, Spain, Revenue Share by Customer Base (%), 2005–2017 213 Figure 126: Biotech Market, Spain, Revenue Analysis by Customer Base ($m), 2005–2017 214 Figure 127: Biotech Market, Spain, Revenue Share by Customer Base (%), 2005–2017 216 Contact: sales@reportsandreports.com for more information.